Accomplishments

    Complete antibody development at UBC; Prototype development; Patent new discoveries

    SCREENING & EARLY DETECTION

    Survival rates are higher for patients whose cancer is detected early.

    NEWS & EVENTS

    BioMark’s CTA application to Health Canada for Phase III Trial June 2012 is approved.

     

    Copyright 2014 by BioMark Tech. All Right Reserved.